195 related articles for article (PubMed ID: 37733919)
21. Exosomal miR-93 derived from hepatocellular carcinoma cell promotes the sorafenib resistance of hepatocellular carcinoma through PTEN/PI3K/Akt pathway.
Bao Y; Xu S; Zhou J; Zhao C; Dai S; Zhang Y; Rao M
J Biochem Mol Toxicol; 2024 Mar; 38(3):e23666. PubMed ID: 38375688
[TBL] [Abstract][Full Text] [Related]
22. HANR Enhances Autophagy-Associated Sorafenib Resistance Through miR-29b/ATG9A Axis in Hepatocellular Carcinoma.
Shi Y; Yang X; Xue X; Sun D; Cai P; Song Q; Zhang B; Qin L
Onco Targets Ther; 2020; 13():2127-2137. PubMed ID: 32210579
[TBL] [Abstract][Full Text] [Related]
23. Silencing of FUN14 Domain Containing 1 Inhibits Platelet Activation in Diabetes Mellitus through Blocking Mitophagy.
Wu Q; Yu S; Peng K
Crit Rev Immunol; 2024; 44(2):25-33. PubMed ID: 38305334
[TBL] [Abstract][Full Text] [Related]
24. Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma.
Shao YY; Chen PS; Lin LI; Lee BS; Ling A; Cheng AL; Hsu C; Ou DL
Br J Cancer; 2022 Jun; 126(12):1806-1814. PubMed ID: 35236936
[TBL] [Abstract][Full Text] [Related]
25. Mitophagy promotes sorafenib resistance through hypoxia-inducible ATAD3A dependent Axis.
Wu H; Wang T; Liu Y; Li X; Xu S; Wu C; Zou H; Cao M; Jin G; Lang J; Wang B; Liu B; Luo X; Xu C
J Exp Clin Cancer Res; 2020 Dec; 39(1):274. PubMed ID: 33280610
[TBL] [Abstract][Full Text] [Related]
26. UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma.
Wu J; Xu X; Wu S; Shi W; Zhang G; Cao Y; Wang Z; Wu J; Jiang C
Cancer Med; 2023 Sep; 12(17):18078-18097. PubMed ID: 37563971
[TBL] [Abstract][Full Text] [Related]
27. [MicroRNA 424-5p promotes the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting Kinesin family member 23].
Liu XL; Sun CF; Yuan Y; Sheng YJ; Deng CL
Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1074-1081. PubMed ID: 36727232
[No Abstract] [Full Text] [Related]
28. HBx Modulates Drug Resistance of Sorafenib-Resistant Hepatocellular Carcinoma Cells.
Liu Y; Liu X; Luo M; Li Y; Li H
Discov Med; 2023 Dec; 35(179):1035-1042. PubMed ID: 38058068
[TBL] [Abstract][Full Text] [Related]
29. Clearance of damaged mitochondria via mitophagy is important to the protective effect of ischemic preconditioning in kidneys.
Livingston MJ; Wang J; Zhou J; Wu G; Ganley IG; Hill JA; Yin XM; Dong Z
Autophagy; 2019 Dec; 15(12):2142-2162. PubMed ID: 31066324
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy.
Zhou J; Feng J; Wu Y; Dai HQ; Zhu GZ; Chen PH; Wang LM; Lu G; Liao XW; Lu PZ; Su WJ; Hooi SC; Ye XP; Shen HM; Peng T; Lu GD
Exp Mol Med; 2022 Nov; 54(11):2007-2021. PubMed ID: 36385558
[TBL] [Abstract][Full Text] [Related]
31. CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma.
Yao J; Wang J; Xu Y; Guo Q; Sun Y; Liu J; Li S; Guo Y; Wei L
Autophagy; 2022 Aug; 18(8):1879-1897. PubMed ID: 34890308
[TBL] [Abstract][Full Text] [Related]
32. Structural insights into the recognition of phosphorylated FUNDC1 by LC3B in mitophagy.
Lv M; Wang C; Li F; Peng J; Wen B; Gong Q; Shi Y; Tang Y
Protein Cell; 2017 Jan; 8(1):25-38. PubMed ID: 27757847
[TBL] [Abstract][Full Text] [Related]
33. Oxyberberine sensitizes liver cancer cells to sorafenib via inhibiting NOTCH1-USP7-c-Myc pathway.
Sun L; He M; Li F; Wu D; Zheng P; Zhang C; Liu Y; Liu D; Shan M; Yang M; Ma Y; Lian J; Xiong H
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38573832
[TBL] [Abstract][Full Text] [Related]
34. Aldehyde Dehydrogenase 2 (ALDH2): A novel sorafenib target in hepatocellular carcinoma unraveled by the proteome-wide cellular thermal shift assay.
Ferreira IC; Torrejón E; Abecasis B; Alexandre BM; Gomes RA; Verslype C; van Pelt J; Barbas A; Simão D; Bandeiras TM; Bortoluzzi A; Rebelo SP
SLAS Discov; 2024 Apr; 29(3):100154. PubMed ID: 38521503
[TBL] [Abstract][Full Text] [Related]
35. FUN14 Domain-Containing 1-Mediated Mitophagy Suppresses Hepatocarcinogenesis by Inhibition of Inflammasome Activation in Mice.
Li W; Li Y; Siraj S; Jin H; Fan Y; Yang X; Huang X; Wang X; Wang J; Liu L; Du L; Chen Q
Hepatology; 2019 Feb; 69(2):604-621. PubMed ID: 30053328
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway.
Li TT; Mou J; Pan YJ; Huo FC; Du WQ; Liang J; Wang Y; Zhang LS; Pei DS
J Biomed Sci; 2021 Aug; 28(1):56. PubMed ID: 34340705
[TBL] [Abstract][Full Text] [Related]
37. NLRX1/FUNDC1/NIPSNAP1-2 axis regulates mitophagy and alleviates intestinal ischaemia/reperfusion injury.
Li S; Zhou Y; Gu X; Zhang X; Jia Z
Cell Prolif; 2021 Mar; 54(3):e12986. PubMed ID: 33432610
[TBL] [Abstract][Full Text] [Related]
38. Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation.
Baechler BL; Bloemberg D; Quadrilatero J
Autophagy; 2019 Sep; 15(9):1606-1619. PubMed ID: 30859901
[TBL] [Abstract][Full Text] [Related]
39. LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.
Li W; Dong X; He C; Tan G; Li Z; Zhai B; Feng J; Jiang X; Liu C; Jiang H; Sun X
J Exp Clin Cancer Res; 2019 May; 38(1):183. PubMed ID: 31053148
[TBL] [Abstract][Full Text] [Related]
40. FUDNC1-dependent mitophagy ameliorate motor neuron death in an amyotrophic lateral sclerosis mouse model.
Guo X; Zhang Z; Gu J; Ke P; Liu J; Meng Y; Zheng W; Que W; Fan R; Luo J; Xiao F
Neurobiol Dis; 2024 May; 197():106534. PubMed ID: 38759931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
